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Abstract Escherichia coli outer membrane protease OmpT has
been characterised as a serine protease based on its inhibitor
profile, but serine protease consensus sequences are absent. By
site-directed mutagenesis we substituted all conserved serines and
histidines. Substitution of His101 and His212 by Ala, Asn or Gln
resulted in variant enzymes with 0.01 and 9^20% residual
enzymatic activity towards a fluorogenic pentapeptide substrate,
respectively. The mutations S140A and S201A did not decrease
activity, while variants S40A and S99A yielded 0.5 and 0.2%
residual activities, respectively. When measured with a dipeptide
substrate the variant S40A demonstrated full activity, whereas
variant S99A displayed at least 500-fold reduced activity. We
conclude that Ser99 and His212 are essential active site residues.
We propose that OmpT is a novel serine protease with Ser99 as
the active site nucleophile and His212 as general base.
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1. Introduction
OmpT (EC 3.4.21.87) is a 33.5 kDa protease of 297 amino
acid residues present in the outer membrane of Escherichia
coli [1,2]. The enzyme cleaves peptides and proteins preferen-
tially between two consecutive basic amino acids [1]. OmpT
has been suggested to be involved in urinary tract disease [3],
in DNA excision repair [4] and in the breakdown of antimi-
crobial peptides [5], but the exact biological function remains
to be elucidated.
Proteases are divided into four classes based on their cata-
lytic mechanism: cysteine proteases, aspartic proteases, metal-
loproteases and serine proteases. OmpT lacks cysteines and
consequently is not a cysteine protease. In all aspartic pro-
teases known so far the amino acid sequence D(T/S)G is con-
served [6] and all metalloproteases characterised to date con-
tain the signature sequence HExxH or HxxEH [7]. OmpT
does not contain either of these motifs. The fourth class com-
prises the serine proteases, which are subdivided into more
than twenty families [8]. Consensus sequences surrounding
the catalytic serine and histidine residues in the well-charac-
terised chymotrypsin family (peptidase family S1; including
trypsin, elastase and others) are GDSGg and tAaHc (showing
absolutely conserved amino acids in capitals) [8]. For the large
subtilisin family (S8) the conserved sequences are GTSma and
nxHGT [8]. OmpT does not contain any of these classical
serine protease consensus sequences, but several serine pro-
teases are known which also lack these motifs, e.g. human
cytomegalovirus [9]. Obviously, it is not possible to classify
OmpT on basis of conserved sequences in the known classes.
An alternative approach to protease classi¢cation is to study
the susceptibility of the enzyme to various protease inhibitors.
The proteolytic activity of OmpT is not or hardly inhibited by
many common protease inhibitors such as the trypsin inhib-
itor tosyl-L-lysine chloromethyl ketone, the metalloprotease
inhibitor EDTA and peptides like antipain and leupeptin,
which are inhibitors of several aspartic and cysteine proteases
[1,10,11]. Only at high concentrations did the serine protease
inhibitors diisopropyl£uorophosphate (DFP) and phenyl-
methylsulfonyl £uoride (PMSF) decrease OmpT activity sig-
ni¢cantly [1]. Based on this inhibitor pro¢le, OmpT was clas-
si¢ed as a member of a novel serine peptidase family called
omptin (S18) [8]. Four proteins homologous to OmpT have
been identi¢ed so far: PgtE of Salmonella typhimurium (ma-
ture part 49% identical to OmpT) [12], Pla of Yersinia pestis
(50% identical) [13], OmpP of E. coli (72% identical) [14] and
SopA of Shigella £exneri (60% identical) [15]. Alignment of
OmpT with these homologues (not shown) demonstrated that
Ser40, Ser99, Ser140, Ser201, His101 and His212 are conserved.
In this study we aimed at identifying the active site serine
and histidine to provide experimental support for the classi-
¢cation of OmpT as a serine protease. Using site-directed
mutagenesis, the four conserved Ser residues of OmpT are
replaced by Ala and the two His residues are substituted by
Ala, Asn and Gln. Membrane fractions of cells expressing the
resulting variants are isolated and residual activities are mea-
sured using two di¡erent spectroscopic assays.
2. Materials and methods
2.1. Materials
DNA restriction enzymes were purchased from New England Bio-
labs. Oligonucleotides were bought from Amersham Pharmacia Bio-
tech. Polyethyleneglycol tert-octylphenyl ether (Triton X-100) was ob-
tained from Serva and polyoxyethylene sorbitanmonolaurate (Tween
20) was obtained from Bio-Rad. The chromogenic substrate IAA-
Arg-Arg-pNA (IAA = indole-3-acetic acid, pNA = p-nitroaniline) was
a generous gift of Dr. A.J. Slotboom (Utrecht University). The £uo-
rogenic substrate Abz-Ala-Arg-Arg-Ala-Tyr(NO2)-NH2 (Abz = o-ami-
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nobenzoyl, Tyr(NO2) = 3-nitrotyrosine) was purchased from Research
Genetics (Huntsville, USA). Anti-OmpT monoclonal antibodies were
obtained by immunisation of a mouse with native wild-type OmpT,
puri¢ed from E. coli as described by Sugimura and Nishihara [1].
Goat anti-mouse IgG alkaline phosphatase conjugate (GAMAP)
was bought from Promega. All other chemicals were of analytical
grade.
2.2. Bacterial strains and plasmids
The E. coli K-12 strain DH5K [16] was used in the cloning proce-
dures. The E. coli strain BL21(DE3) [17] lacks the ompT gene and was
used for expression. Plasmids pND9 and pND10 [18] are derivatives
of pUC19 [19], containing the ompT gene including its own promoter
sequence oriented clockwise and counterclockwise with the lac pro-
moter, respectively.
Mutations were introduced into plasmid pND10 using PCR accord-
ing to the manufacturers protocol provided with the QuikChange
Site-Directed Mutagenesis Kit (Stratagene). To facilitate the screening
for the mutations, silent mutations resulting in the introduction or
deletion of restriction sites were made concomitantly with the amino
acid mutations. All mutations except S40A, S140A and S201A were
subcloned from the pND10 derivative into plasmid pND9 as follows.
For mutations at position 99 or 101, the pND10-derived plasmids
were digested with HincII and XcmI, followed by cloning of the
257 bp fragment containing the desired mutation into HincII/XcmI
digested pND9. For mutations at position 212, the pND10-derived
plasmids were digested with AccI and A£II, followed by cloning of the
580 bp fragment containing the desired mutation into AccI/A£II di-
gested pND9. The sequences of the relevant parts of the constructed
plasmids were checked by restriction enzyme analysis and DNA se-
quencing.
2.3. Expression of OmpT and isolation of membrane fractions
After transformation by the various plasmids, BL21(DE3) cells
were grown overnight in 10 ml LB medium [20] with 50 Wg/ml ampi-
cillin at 37‡C. The optical density at 600 nm was measured and cells
corresponding to 6 ml culture with A600 of 1.0 were harvested by
centrifugation. The pellet was washed with 0.15 M NaCl and resus-
pended in 1 ml 2 mM EDTA, 50 mM Tris, pH 8. Cells were disrupted
by sonication at 0‡C and intact cells were removed by short centrifu-
gation (15 000Ug for 30 s). The supernatant was centrifuged at
15 000Ug for 15 min at 4‡C and the resulting membrane pellet was
resuspended in 200 Wl bu¡er A (0.1% Triton X-100, 50 mM Tris, pH
7.5).
2.4. Analysis of OmpT in isolated membrane fractions
The total amount of protein in the isolated membrane fractions was
determined using the Bio-Rad protein assay with bovine serum albu-
min as a reference. Samples of membrane fractions corresponding to
equal amounts of total protein were mixed with loading bu¡er [20]
and loaded on a 11% SDS^PAGE gel [21] either directly or after 5 min
incubation at 100‡C. After electrophoresis, proteins were transferred
to a nitrocellulose membrane by Western blotting [22]. OmpT was
detected using anti-OmpT monoclonal antibodies and GAMAP as
described elsewhere [20].
2.5. Enzymatic activity assays
Samples of membrane fractions were diluted in bu¡er A to appro-
priate concentrations and OmpT activity was measured using two
di¡erent spectroscopic assays.
The chromogenic substrate IAA-Arg-Arg-pNA was used in a col-
orimetric assay described elsewhere [18]. Assay conditions were
0.5 mM IAA-Arg-Arg-pNA, 1 mM Tween 20, 20 mM Mes, pH 7.0
and 0.1 U/ml aminopeptidase M. OmpT speci¢c cleavage between the
two arginines results in the liberation of Arg-pNA. This product is
subsequently cleaved by aminopeptidase M resulting in the release of
pNA, which is detected spectrophotometrically at 405 nm. The in-
crease in absorbance was recorded and activities were determined
from the linear part of the curves. Using A405 = 10 200 M31 cm31
for pNA [23], activities were calculated in enzymatic units U
( =Wmol substrate/min).
The internally quenched £uorogenic substrate Abz-Ala-Arg-Arg-
Ala-Tyr(NO2)-NH2 was used in a £uorimetric assay as described pre-
viously [18]. Assay conditions were 6 WM substrate, 1 mM Tween 20,
5 mM EDTA, 10 mM Bistris, pH 6.5. Activity was measured in a
£uorimeter using excitation and emission wavelengths of 325 and 430
nm, respectively. After recording the initial linear increase in £uores-
cence, 20 Wg of trypsin was added to determine the £uorescence of
completely hydrolysed substrate, which enabled calculation of the
activity in enzymatic units.
3. Results
3.1. Expression of OmpT
BL21(DE3) cells expressing the active site variants of
OmpT, wild-type OmpT or no OmpT were grown in triplicate
and membrane fractions were isolated. Concentrations of to-
tal protein were determined and used as a measure for the
amount of OmpT. To validate the assumption that expression
levels of the OmpT variants were similar, Western blot anal-
ysis was performed with all samples containing equal amounts
of total protein. No OmpT was detected in samples of
BL21(DE3) transformed with plasmid pUC19 as expected
(data not shown). In all other samples the major protein
band corresponded to a protein with an apparent molecular
mass of about 35 kDa, which corresponds to OmpT with a
calculated molecular mass of 33,478 Da (Fig. 1). The expres-
sion level of the variants encoded by plasmid pND9 was on
average approximately three times higher than that of variants
encoded by pND10. This e¡ect can be explained by the coun-
terclockwise and clockwise orientation of the lac promoter
with the ompT gene in pND9 and pND10, respectively.
Wild-type and all variants were well expressed and the expres-
sion levels of variants encoded by the same plasmid were
comparable within a factor of three. Although these di¡er-
ences were signi¢cant, they were acceptable for our purpose
to identify active site mutations, since for such mutations a
decrease in activity of at least 100 times was expected. A
second band with low intensity was observed at approxi-
mately 31 kDa. This band has previously been shown to be
a degradation product of OmpT, resulting from autoproteo-
lytic cleavage between residues Lys217 and Arg218 [18]. When
the samples were not boiled before loading, the apparent mo-
lecular mass of OmpT was about 29 kDa (data not shown).
This so-called heat-modi¢ability is generally observed for out-
er membrane proteins [24] and occurs because the putative
L-barrel fold of the protein is not denatured by the presence
of SDS alone, resulting in a relatively fast migrating protein.
The observation of this e¡ect is a good measure for proper
Fig. 1. Western blot analysis of OmpT in isolated outer membrane
fractions. Samples corresponding to 0.5 Wg of total protein were in-
cubated for 5 min in loading bu¡er at 100‡C. Lane 1, wild-type en-
coded by pND9. Lane 2, wild-type encoded by pND10. Lanes 3^6,
variants S40A, S99A, S140A and S201A encoded by pND10. Lanes
7^13, variants S99A, H101A, H212A, H101N, H212N, H101Q and
H212Q encoded by pND9. Numbers on the left refer to molecular
masses of marker proteins.
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folding and assembly in the outer membrane and all active site
variants ful¢lled this criterion.
3.2. Activity measurements of serine variants
The enzymatic activity of OmpT in the isolated membrane
fractions was measured with a colorimetric assay. For all var-
iants, membrane fractions of three independent cell cultures
were measured. The average activities are shown in Table 1.
When only bu¡er was added, a background increase in absor-
bance could be recorded. This apparent activity was equal to
that of membrane fractions from BL21(DE3)(pUC19) cells
(no OmpT expression) and corresponded to a value of
5.3 þ 0.4 U/g total protein. The activity of wild-type OmpT
encoded by plasmid pND10 was 2.3-fold lower than that of
wild-type encoded by pND9, which is in agreement with the
di¡erence in expression levels (Fig. 1). We therefore used the
activity of wild-type OmpT encoded by plasmid pND10 as a
reference for variants encoded by pND10 derivatives (and
correspondingly for plasmid pND9). No activity was detect-
able for OmpT variant S99A (in plasmid pND10), whereas
activity comparable to that of wild-type was measured for
mutant proteins S40A, S140A and S201A. Since activity was
maintained for the latter three variants, Ser40, Ser140 and
Ser201 were concluded not to be active site residues. A se-
quenced fragment of the gene carrying the S99A mutation
was subcloned into plasmid pND9 and no activity was detect-
able for the S99A variant encoded by this plasmid as well
(Table 1), con¢rming that Ser99 is the active site serine. In
order to determine the activity of the serine variants more
accurately, a sensitive £uorimetric assay was used. The meas-
ured activities of the S140A and S201A variants in this assay
were consistent with those in the colorimetric assay (Table 1).
The residual activity of the S99A variant was 0.2%, in agree-
ment with the identi¢cation of Ser99 as an active site residue.
Interestingly, the residual activity of the S40A variant in this
assay was only 0.5%.
3.3. Activity measurements of histidine variants
All histidine mutations were sequenced and subcloned into
plasmid pND9 to rule out the presence of additional muta-
tions a¡ecting enzymatic activity. In the colorimetric assay, no
activity was detectable when His212 was replaced by Ala, Asn
or Gln (Table 1). Although activities were low for the His101
variants, they were signi¢cantly above the background with
highest activity for H101Q (1.0%). Since replacement of His101
and His212 both resulted in a large decrease in activity, mea-
surement of the variants in the more sensitive £uorimetric
assay was necessary to identify the active site histidine. As
shown in Table 1, substitution of His101 resulted in activities
that were only ¢ve- to ten-fold lower than wild-type activity.
In contrast, the activities of variants with Ala, Asn or Gln at
the position of His212 were at least 10 000-fold lower than that
Fig. 2. Topology model for E. coli OmpT (adapted from [18]).
Numbers refer to the amino acid positions in mature OmpT. Resi-
dues in L-strands are shown in squares; other residues are in circles.
Hydrophobic L-strand residues pointing to the lipid phase are
shaded. The grey area represents the approximate position of the
membrane relative to the protein. The N-terminus and the short
turns (T1^T4) are localised in the periplasm and the large loops
(L1^L5) face the extracellular side of the membrane. Active site resi-
dues Ser99 and His212 are printed bold. The autoproteolytic cleavage
site Lys217-Arg218 is given in italics.
Table 1
Activities of OmpT and its variants measured in two di¡erent spectroscopic assays
OmpT Plasmid Activity in colorimetric assay
(U/g total protein)
Activity in £uorimetric assay
(U/g total protein)
None pUC19 5.3 þ 0.4 0a
Wild-type pND10 120.0 þ 6 12000 þ 4000
S40A pND10 243.0 þ 34 60 þ 17
S99A pND10 5.3 þ 0.2 26 þ 6
S140A pND10 33.0 þ 6 12000 þ 7000
S201A pND10 142.0 þ 25 18000 þ 11000
Wild-type pND9 275.0 þ 73 48000 þ 24000
S99A pND9 5.3 þ 0.3 41 þ 17
H101A pND9 6.3 þ 0.3 4500 þ 1500
H101N pND9 6.0 þ 0.6 6700 þ 1400
H101Q pND9 8.0 þ 0.2 9700 þ 2900
H212A pND9 5.3 þ 0.4 5 þ 2
H212N pND9 5.5 þ 0.3 3 þ 2
H212Q pND9 5.3 þ 0.1 4 þ 2
aNo detectable increase in £uorescence.
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of wild-type. These results show that His212 is an active site
residue.
4. Discussion
The inhibitor pro¢le of OmpT [1,10,11] suggested that the
enzyme is a serine protease and in this study we tested that
hypothesis by site-directed mutagenesis of all conserved serine
and histidine residues. Single mutant proteins of OmpT were
made with conserved serine residues replaced by alanine or
with conserved histidine residues substituted by alanine, as-
paragine or glutamine. Due to variations in expression levels
for the di¡erent mutant proteins there was a considerable
spread in the measured activities (Table 1). However, for
the aim of active site residue identi¢cation this was not a
major drawback. By SDS^PAGE and Western blotting it
was shown that all variants were folded correctly.
Two di¡erent spectroscopic assays were used to measure the
residual enzymatic activities of the OmpT variants. For var-
iants in which Ser40 or His101 was replaced the outcome of the
two assays showed high variability. Variant S40A displayed
207 and 0.5% activity in the colorimetric and the £uorimetric
assay, respectively. In contrast, variants with His101 substi-
tuted by Ala, Asn or Gln demonstrated on average about
30-fold higher relative residual activity in the £uorimetric as-
say. When the assays are compared, two important di¡erences
can be noted. Firstly, it is clear from Table 1 that the absolute
activities for equal amounts of wild-type OmpT are two or-
ders of magnitude higher in the £uorimetric assay. Secondly,
the £uorogenic substrate is larger than the chromogenic sub-
strate, with six and three backbone carbonyl moieties, respec-
tively. These di¡erences are illustrated by our recent ¢ndings
[18] that the kinetics of wild-type OmpT in the colorimetric
assay were characterised by low a⁄nity and activity (KM =
0.5 mM, kcat = 0.4 s31), whereas these parameters were sub-
stantially better in the £uorimetric assay (KM = 0.3 WM,
kcat = 38 s31). Substitution of an amino acid in an enzyme
can lead to a loss of activity because the original residue
participates directly in enzymatic catalysis. Alternatively, the
substituted residue may be involved indirectly via interactions
with the substrate and we propose that this is the case for
residues Ser40 and His101 of OmpT. We hypothesise that the
side chain of Ser40 interacts with the N- or C-terminus of the
large £uorogenic substrate, which can explain the large loss of
activity for the S40A variant in the £uorimetric assay. In the
colorimetric assay Ser40 would not be able to interact with the
shorter substrate, which explains why the activity is not af-
fected in this assay. Furthermore, we believe that His101, being
only two residues away from Ser99, may be required for cor-
rect positioning of the substrate into the active site to make
the Arg-Arg peptide bond optimally accessible for the nucle-
ophilic attack by Ser99. This productive binding may be
achieved more easily for the larger £uorogenic substrate be-
cause of the potential additional interactions. In this respect it
is interesting to note that the residual activity of variant
H101Q was substantially higher than that of variant
H101A. This suggests that glutamine can take over the hydro-
gen-bonding capacity of the histidine residue, indicating that
His101 may be involved in substrate interaction indeed. Addi-
tional studies are needed to con¢rm our hypotheses, prefera-
bly by solving the crystal structure of OmpT in complex with
a substrate analogue.
In contrast to the con£icting results of the two assays for
replacement of Ser40 and His101, the results of both assays
were consistent for all other mutations (Table 1). We conclude
that Ser99 and His212 are active site residues of OmpT. We
propose that Ser99 performs the nucleophilic attack on the
scissile peptide bond of the substrate, catalysed by residue
His212 that acts as a general base by abstracting a proton
from the hydroxyl group of Ser99. However, other possibilities
for the exact function of the active site serine in OmpT should
not be ruled out, since the residual activity of OmpT variant
S99A was relatively high (0.2%) when compared to variants of
other serine proteases in which the active site serine is sub-
stituted. Removal of the catalytic serine in subtilisin for ex-
ample reduced the kcat value of the protease 106 times [25].
Most serine proteases have an active site composed of a Ser-
His-Asp/Glu catalytic triad [8], in which the carboxylate
group of the third member stabilises the positive charge of
the protonated histidine. Within the omptin family eleven
acidic amino acids are conserved which are candidates for
being the third member besides Ser99 and His212. Identi¢cation
of this residue was beyond the scope of the present study, but
is currently pursued.
Active site residue His212 of OmpT is located close to res-
idues Lys217 and Arg218, which form an autoproteolytic cleav-
age site in OmpT. Mutation of these residues to stabilise the
protein led to signi¢cant losses in enzymatic activity [18]. We
now understand these observations by reasoning that the mu-
tations could have disturbed the active site conformation and/
or substrate binding.
We previously proposed a L-barrel topology model for
OmpT [18]. The recently published crystal structure of the
homologous E. coli OmpX protein [26] (with 31 of the 148
amino acids of mature OmpX identical to OmpT) enabled us
to re¢ne this model (Fig. 2). The active site residues Ser99 and
His212 are positioned in two di¡erent extracellular loops, re-
stricting the folding of both loops because of the required
close proximity between these two residues. The extracellular
location of the active site of OmpT is experimentally sup-
ported by the observation that T7 RNA polymerase and ini-
tiation factor IF2K were degraded by OmpT when added to
intact E. coli cells [27,28]. Furthermore, OmpT activity was
also observed when intact E. coli cells were measured in our
colorimetric assay (unpublished results). At present, the only
outer membrane enzyme for which the active site and the
crystal structure are known is E. coli outer membrane phos-
pholipase A [29^31]. Interestingly, the active site serine
(Ser144) and histidine (His142) of this enzyme are located on
one of the L-strands, separated by only one amino acid. This
indicates that at least two possibilities exist for the active site
architecture of serine hydrolases that reside in the outer mem-
brane of Gram-negative bacteria.
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